Loading organizations...
Shavit Capital is an investment practice providing late-stage capital to Israeli and Israeli-related companies. The firm offers equity mezzanine or bridge financing for businesses with proven technologies and strong management. It targets companies preparing for initial public offerings on international exchanges or dual listings, guiding them to public market readiness.
Founded by Gary Leibler, Managing Partner, Shavit Capital emerged from recognizing a need for dedicated late-stage funding in the Israeli tech ecosystem. Leibler established the firm to offer strategic financial support, empowering mature companies to transition to public markets. This enables management to execute listing strategies.
Shavit Capital invests in successful late-stage technology companies seeking capital for public market transition. Its vision is to be a pivotal partner in their global expansion. The firm facilitates entry onto major international exchanges, leveraging expertise to enhance credibility and optimize the listing process.
Key people at Shavit Capital.
Shavit Capital was founded in 2008 by Gary Leibler (Co-Founder & Managing Partner).
Shavit Capital has 5 tracked investments across 5 companies. The latest tracked deal is $100.0M Series D in Lightricks in September 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2021 | Lightricks | $100.0M Series D | Hanaco Ventures, Thilo Semmelbauer | Coatue, Lazerow Ventures, Left Lane Capital, Will Szczerbiak, Altshuler Shaham, Claltech, Goldman Sachs, Greycroft, Harel Insurance Investments & Financial Services, Migdal Insurance |
| Mar 22, 2021 | Veev Group | $210.4M Series C | — | Migdal Insurance, More Investment House, Psagot Investment House |
| Jun 1, 2020 | Alpha Tau Medical | $26.0M Series B | — | Aleph VC, Battery Ventures, Catapult Capital, Citi Ventures, Hillsven Capital, Norwest Venture Partners, OurCrowd, Recursive Ventures, SignalFire, The HIT Forge, Tribeca Venture Partners, UpWest, Clark Landry, Curtis LEE, Evan Williams, Michael Birch, Oliver Thylmann, Medison Ventures |
| Feb 24, 2016 | PolyPid | $22.0M Series D | Aurum Ventures, Shavit Capital | Chaim Hurvitz |
| May 27, 2015 | Mapi Pharma | $10.0M Series A | Shavit Capital | Ehud Marom |
Key people at Shavit Capital.